Literature DB >> 22173489

Inhibitory effects of Rap1GAP overexpression on proliferation and migration of endothelial cells via ERK and Akt pathways.

Wenyi Li1, Bi Jin1, Lynn A Cornelius2, Bin Zhou1, Xiaoyang Fu1, Dan Shang1, Hong Zheng3.   

Abstract

Rap1 is expressed in human umbilical vein endothelial cells (HUVECs). Rap1-GTPase activating protein (Rap1GAP), with its specific target, Rap1, has been shown to be important in the regulation of many physiological and certain pathological processes. In this study, we investigated the effect of Rap1GAP expression on endothelial cell function, or, more specifically, proliferation and migration of endothelial cells. HUVECs were transfected with pcDNA3.1 (empty vector), pcDNA3.1 containing Flag-tagged-Rap1GAP or Myc-tagged-Rap1N17. The proliferation, migration and tube formation were examined and compared among the 3 groups. Expression of Rap1, Rap1GAP, extracellular signal-regulated kinase (ERK), phospho-ERK, Akt, phosphor-Akt was detected by Western blotting. The results showed that the proliferation, migration and tube formation were significantly reduced in Rap1GAP- and Rap1N17-transfected HUVECs as compared with empty vector-transfected control. These changes were coincident with increased expression of Rap1GAP and decreased expression of activated Rap1, phospho-ERK and -Akt. After treatment of Rap1GAP-transfected HUVECs with a stimulator of Rap1 guanine-nucleotide-exchange factor (Rap1GEF) 8CPT-2'OMe-cAMP, it was found that Rap1 activity was decreased as compared with empty vector-transfected control. Pretreatment of HUVECs with an ERK inhibitor PD98059 or a PI3K inhibitor LY294002 prior to stimulation not only blocked 8CPT-2'OMe-cAMP-induced phosphorylation of ERK and Akt, but also significantly reduced cell proliferation and migration. Finally, we examined the effect of vascular endothelial growth factor (VEGF) on HUVECs overexpressing Rap1GAP. VEGF-stimulated Rap1 activity, phosphorylation of ERK and Akt, cyclin D1 expression and cell proliferation were repressed in HUVECs overexpressing Rap1GAP as compared to empty vector-transfected control. Taken together, our findings demonstrate that Rap1GAP/Rap1 and their downstream effectors regulate proliferation and migration of HUVECs via ERK and Akt pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173489     DOI: 10.1007/s11596-011-0667-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  40 in total

1.  Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes.

Authors:  Hisakazu Fujita; Shigetomo Fukuhara; Atsuko Sakurai; Akiko Yamagishi; Yuji Kamioka; Yoshikazu Nakaoka; Michitaka Masuda; Naoki Mochizuki
Journal:  J Biol Chem       Date:  2004-11-29       Impact factor: 5.157

2.  A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.

Authors:  Robert C Doebele; Frank T Schulze-Hoepfner; Jia Hong; Alexandre Chlenski; Benjamin D Zeitlin; Kushboo Goel; Suzana Gomes; Yuru Liu; Mark K Abe; Jacques E Nor; Mark W Lingen; Marsha Rich Rosner
Journal:  Blood       Date:  2009-08-26       Impact factor: 22.113

3.  Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.

Authors:  Lizhi Zhang; Li Chenwei; Redah Mahmood; Kenneth van Golen; Joel Greenson; Gangyong Li; Nisha J D'Silva; Xiangquan Li; Charles F Burant; Craig D Logsdon; Diane M Simeone
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

4.  Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors.

Authors:  Hui Zuo; Manoj Gandhi; Martin M Edreira; Daniel Hochbaum; Vishwajit L Nimgaonkar; Ping Zhang; James Dipaola; Viktoria Evdokimova; Daniel L Altschuler; Yuri E Nikiforov
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

5.  Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.

Authors:  Shuk-Mei Ho; Kin-Mang Lau; Samuel Chi-Ho Mok; Viqar Syed
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

6.  Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4.

Authors:  Laure Favot; Thérèse Keravis; Claire Lugnier
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

7.  Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice.

Authors:  Daisuke Ishida; Kohei Kometani; Hailin Yang; Kiyokazu Kakugawa; Kyoko Masuda; Kazuhiro Iwai; Misao Suzuki; Shigeyoshi Itohara; Tatsutoshi Nakahata; Hiroshi Hiai; Hiroshi Kawamoto; Masakazu Hattori; Nagahiro Minato
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.

Authors:  Raj S Mitra; Mitsuo Goto; Julia S Lee; Diana Maldonado; Jeremy M G Taylor; Quintin Pan; Thomas E Carey; Carol R Bradford; Mark E Prince; Kitrina G Cordell; Keith L Kirkwood; Nisha J D'Silva
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

10.  Essential role for ERK2 mitogen-activated protein kinase in placental development.

Authors:  Naoya Hatano; Yoshiko Mori; Masatsugu Oh-hora; Atsushi Kosugi; Takahiko Fujikawa; Naoya Nakai; Hitoshi Niwa; Jun-ichi Miyazaki; Toshiyuki Hamaoka; Masato Ogata
Journal:  Genes Cells       Date:  2003-11       Impact factor: 1.891

View more
  6 in total

Review 1.  Ras and Rap1: A tale of two GTPases.

Authors:  Seema Shah; Ethan J Brock; Kyungmin Ji; Raymond R Mattingly
Journal:  Semin Cancer Biol       Date:  2018-04-03       Impact factor: 15.707

2.  Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p.

Authors:  Haixia Li; Jinghui Liang; Jiang Wang; Jingyi Han; Shuang Li; Kai Huang; Chuanyong Liu
Journal:  Cancer Commun (Lond)       Date:  2021-02-27

3.  RNA sequencing analysis reveals increased expression of interferon signaling genes and dysregulation of bone metabolism affecting pathways in the whole blood of patients with osteogenesis imperfecta.

Authors:  Lidiia Zhytnik; Katre Maasalu; Ene Reimann; Aare Märtson; Sulev Kõks
Journal:  BMC Med Genomics       Date:  2020-11-23       Impact factor: 3.063

4.  Notoginsenoside R2 induces colonic microvascular injuries via regulating the Rap1GAP/PI3K/Akt signaling pathway.

Authors:  Ping Tao; Jiang Lin; Beiping Zhang; Shiying Wang
Journal:  Ann Transl Med       Date:  2021-12

5.  Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation.

Authors:  Seema Shah; Ethan J Brock; Ryan M Jackson; Kyungmin Ji; Julie L Boerner; Bonnie F Sloane; Raymond R Mattingly
Journal:  Neoplasia       Date:  2018-08-22       Impact factor: 5.715

6.  G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.

Authors:  Hui Pei; Wei Wang; Di Zhao; Hongyan Su; Guohai Su; Zhuo Zhao
Journal:  Int J Biol Sci       Date:  2019-01-06       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.